Skip to content

A randomized controlled clinical study of implant supported removable partial denture in repairing Kennedy Class I and II dentition defects

A randomized controlled clinical study of implant supported removable partial denture in repairing Kennedy Class I and II dentition defects

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200064579
Enrollment
Unknown
Registered
2022-10-12
Start date
2022-11-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dentition defects

Interventions

Group 1 :The traditional removable partial denture was used first, and then the implant supported removable partial denture was used
Group 2:Firstly, "implant-supported removable partial denture" was used for restoration, and then "traditional removable partial denture" was used for restoration

Sponsors

The Ninth People's Hospital Affiliated to Medical College of Shanghai Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Age between 35-70 years old, gender is not limited; 2. Patients with Kennedy class I and class II dentition defects; 3. The bone quality and bone quantity in the free end missing area meet the requirements for implanting implants with a diameter of 3.5 mm and a length of more than 8.0 mm; 4. The subjects have good compliance and can guarantee to see a doctor on time during the trial.

Exclusion criteria

Exclusion criteria: 1. Physical and mental health problems hinder the later maintenance of implants; 2. There are contraindications to implant surgery; 3. Severe jaw differences; 4. Severe bruxism at night; 5. People who abuse drugs or alcohol; 6. Heavy smokers; 7. Those receiving radiotherapy or chemotherapy; 8. Long-term treatment with steroid hormones, immunosuppressants or bisphosphonates; 9. Patients with insulin-dependent diabetes and uncontrolled diabetes; 10. Patients with chronic kidney disease or liver disease; 11. Severe cardiopulmonary diseases with systemic and local bone metabolic diseases; 12. Patients with hemophilia or those at risk of bacterial endocarditis; 13. Immunocompromised patients, including HIV patients.

Design outcomes

Primary

MeasureTime frame
Masticatory efficiency;

Secondary

MeasureTime frame
Digital occlusion analysis;Oral Health Impact Scale;

Countries

China

Contacts

Public ContactHuang Qingfeng

The Ninth People's Hospital Affiliated to Medical College of Shanghai Jiaotong University

hqfyy@163.com+86 13918307666

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026